Bulletin
Investor Alert

CRISPR Therapeutics AG

NAS: CRSP

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201181046/composite

$

78.55

Change

-0.24 -0.30%

Volume

Volume 349,842

Nov 26, 2021, 4:52 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201181046/composite

Previous close

$ 80.92

$ 78.79

Change

-2.13 -2.63%

Day low

Day high

$78.46

$82.00

Open
Open: 79.57

52 week low

52 week high

$77.42

$220.20

Open

Market cap

$6.03B

Average volume

1.50M

P/E ratio

16.55

Rev. per Employee

$1,754

EPS

4.76

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crsp

MarketWatch News on CRSP

  1. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  2. Beam Gets FDA Nod for First Gene-Editing Trial

    8:10 a.m. Nov. 9, 2021

    - Barron's Online

  3. Prime Is the Newest Gene Editing, and It's Getting Better

    6:11 p.m. Oct. 20, 2021

    - Barron's Online

  4. Crispr Therapeutics stock price target cut to $101 from $139 at Stifel Nicolaus

    5:44 a.m. Oct. 13, 2021

    - Tomi Kilgore

  5. This Fund Is Winning Big by Betting on Stocks That Help Humanity

    6:37 a.m. Sept. 27, 2021

    - Barron's Online

  6. Intellia Stock Is Rocketing Because of a Gene-Editing Breakthrough

    8:21 a.m. June 30, 2021

    - Barron's Online

  7. First In-Vivo Gene Editing Data Look Good for Intellia

    7:40 a.m. June 28, 2021

    - Barron's Online

  8. Vertex Shares Fall as Drug Fails. Analysts Say It's Time to Buy.

    7:37 a.m. June 11, 2021

    - Barron's Online

  9. How a Cloud Is Lifting from Bluebird and Other Gene Therapy Stocks

    12:38 p.m. June 7, 2021

    - Barron's Online

  10. 5 Undervalued Stocks in Biopharma, the Sweet Spot in Healthcare

    4:40 p.m. April 21, 2021

    - Barron's Online

  11. Crispr Therapeutics Is Upgraded After $900 Million Deal

    9:33 p.m. April 21, 2021

    - Barron's Online

  12. Biotech stocks are a buy — especially these 18 picks

    1:02 p.m. March 13, 2021

    - Michael Brush

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/crsp

Other News on CRSP

  1. CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow

    2:28 p.m. Nov. 23, 2021

    - Seeking Alpha

  2. CRISPR's Life-Saving Technology Has Massive Potential

    1:07 p.m. Nov. 22, 2021

    - Seeking Alpha

  3. Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?

    11:31 a.m. Nov. 21, 2021

    - Motley Fool

  4. Better Buy: Vertex Pharmaceuticals vs. CRISPR

    7:00 a.m. Nov. 20, 2021

    - Motley Fool

  5. 2 Beaten-Down Growth Stocks You Can Buy Right Now

    11:15 a.m. Nov. 17, 2021

    - Motley Fool

  6. Vertex Stock: Slowing Growth, But It's Attractively Valued Now

    5:01 p.m. Nov. 16, 2021

    - Seeking Alpha

  7. The Key Behind Vertex's Great Q3 Results

    6:47 a.m. Nov. 11, 2021

    - Motley Fool

  8. Cathie Wood's Buying Beam Therapeutics -- Should You?

    9:15 a.m. Nov. 9, 2021

    - Motley Fool

  9. Bluebird bio hurt by downgrades after oncology spinoff

    10:51 a.m. Nov. 8, 2021

    - Seeking Alpha

  10. Loading more headlines...
/news/pressrelease/company/us/crsp

Press Releases on CRSP

  1. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.